logo

Iovance Biotherapeutics Inc (IOVA) Stock: The Story of a 52-Week Stock Range

CSCO Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Iovance Biotherapeutics Inc’s current trading price is -24.46% away from its 52-week high, while its distance from the 52-week low is 331.36%. The stock’s price range for this period has been between $3.21 and $18.33 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.57 million for the day, a number notably lower than the average daily volume of 8.94 million over the last three months.

Iovance Biotherapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $18.33 on 02/28/24, while the lowest value for the same period was recorded at $3.21 on 10/19/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 69.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.87B and boasts a workforce of 557 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 11.45, with a change in price of +7.42. Similarly, Iovance Biotherapeutics Inc recorded 8,514,783 in trading volume during the last 100 days, posting a change of +116.04%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.

IOVA Stock Stochastic Average

Iovance Biotherapeutics Inc’s raw stochastic average for the past 50 days is presently 38.18%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 86.80%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 89.07% and 79.48%, respectively.

IOVA Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 70.32%.However, over the last six months, we can see a weaker performance of 228.90%. Over the last 30 days, the price of IOVA has fallen by 5.94%. And in the last five days, it has surged by 17.54%.

Most Popular